The emerging treatment of this peptide represents a major advance in the management of type 2 diabetes. Unlike existing therapies, tirzepatide affects multiple pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatidepeptide188476.ampblogs.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-79037853